Assertion: duchenne muscular dystrophy | /r/HasProperty | developed by sarepta therapeutics
Facets:
Source sentences:
text: GALGT2 (B4GALNT2 ) is an experimental gene therapy for Duchenne muscular dystrophy (DMD) being developed by Sarepta Therapeutics and tested in collaboration with the Nationwide Children’s Hospital in the U.S.